Chief Executive Officer
Lisa Gable has served four U.S. presidents and two governors, counseled Fortune 500 CEOs, and represented global public-private partnerships and nonprofits with an end goal of moving organizations to higher levels of performance.
As the former President of the Healthy Weight Commitment Foundation, Lisa created and led a coalition of food and beverage industry corporations and public health and government agencies resulting in the reduction of 6.4 trillion calories from the American diet.
Lisa was appointed the first female U.S. Commissioner General to the 2005 Aichi World EXPO, holding the personal rank of Ambassador, served as a U.S. Delegate to the United Nations Commission on the Status of Women and served in the Reagan White House and Defense Department. Her corporate experience included serving as senior vice president of Global Public Policy at PepsiCo and 15 years in Silicon Valley. Among her varied volunteer activities, she has served on several boards including as a National Trustee for the Boys and Girls Club of America, a board member for Girl Scouts of the USA and as a member of the Institute of Medicine Roundtable on Obesity Solutions. A published writer, Gable also had recurring media appearances including four years as a regularly scheduled guest with Lifetime’s national morning program The Balancing Act.
She is a graduate of University of Virginia and holds an MA from Georgetown University.
Thomas B. Casale, MD
Chief Medical Advisor for Operations
Professor of Medicine, University of South Florida
Dr. Thomas Casale joined the University of South Florida in Tampa in October of 2013, as Professor of Medicine and Pediatrics and Chief of Clinical and Translational Research. Prior to that, Dr. Casale was Professor of Medicine and Medical Microbiology and Immunology and Chief of Allergy/Immunology at Creighton University in Omaha. Dr. Casale did an Allergy/Immunology fellowship at the National Institutes of Health (NIH), where he was chief medical staff fellow. From 1984 to 1996, he was at the University of Iowa where he attained the rank of Professor of Medicine and Director of Allergy/Immunology
Dr. Casale's clinical and basic research interests are directed toward determination and treatment of the pathophysiologic mechanisms involved in asthma, COPD and allergic diseases. He has participated in over 250 multi-site clinical trials, especially for new immune response modifiers for airway diseases. He has been on advisory boards for the development of many clinical trials for novel treatments and the lead investigator on several. He has published over 400 scientific papers, reviews and chapters on his research.
Chief of Staff
As FARE’s Chief of Staff, Troy works closely with FARE Boards, volunteer leaders and with senior leadership in developing and executing FARE’s annual strategy. Additionally, working with FARE's education team, Troy oversees education and program development. He worked in marketing and membership for 16 years, spending the last 11 years concentrated on the nonprofit and association sectors. Most recently, Troy headed membership engagement at Independent Sector, where he oversaw multiple programs to grow the IS member community, drive engagement in IS programming and the creation and implementation of a new concept to expand a standalone annual conference into a year-long series of regional events culminating in a national gathering of nonprofit sector leaders. Previously, Troy was vice president of member and industry development with the American Society of Interior Designers. There he was responsible for managing all aspects of membership, volunteer leader training and development, as well as sponsorship and fund development for the ASID Foundation.
Troy is also an active volunteer and currently a member of the Trevor Project’s DC Ambassadors Committee. Prior to this, he was a member of the American Society of Association Executives’ Membership Section Council for three years and has volunteered on advisory boards and committees for the Alliance to Save Energy, Net Impact, and Special Olympics. Troy received a B.S. in Business Administration from Birmingham-Southern College and he is an alumnus of the Center For Nonprofit Leadership at Georgetown University.
Vanita Boswell, PhD
Campaign and Creative Director
Vanita is a veteran fundraiser and strategist with over 20 years of fund development and brand marketing experience. She has led conversations with the United Nations Status on Women, Global CSR Summits, and National Marketing Conferences. In 2014, Vanita launched The VALO Group—a social impact consultancy that raises investments by designing purpose driven campaigns and strategies. VALO’s portfolio of impact partners includes FARE, Girls Who Code, UNICEF, NYC Rescue Mission, The Bowery Mission, Young Life, Thankful, and New York University. Vanita received a Service Award from the FBI, honoring VALO’s work in Public Service and Government. She is also the Executive Producer of the social justice film Rooting for Roona. Prior to launching VALO, Vanita served as the Chief Development Executive for Girl Scouts of the USA, where she designed ToGetHerThere, a $1B fundraising campaign for girls – the largest in US history. Vanita holds a MS in Counseling Psychology and a PhD in Sociology.
Sherry Lynn Fazio
Interim Chief Development Officer
Sherry Lynn Fazio has been working in nonprofit fundraising, event planning and communications for the past 19 years in New York and New Jersey. Ms. Fazio currently owns and operates SG Strategy, a boutique consulting firm, where she works with clients on nonprofit infrastructure development, social media marketing, digital strategy, volunteer engagement, and event planning. Prior to consulting, Sherry spent eight years managing external affairs for a small nonprofit that grew by millions under her leadership. She has presented all over the country on using social media for nonprofits, volunteer management, event planning and other topics benefiting nonprofit organizations at local and national conferences. Ms. Fazio has her BA from Muhlenberg College and a Masters in Applied Social & Community Psychology from Fairleigh Dickinson University.
Ruchi Gupta, MD, MPH
Medical Advisor, Policy, Education and Public Health
Dr. Ruchi Gupta is a Professor of Pediatrics and Medicine at Northwestern University Feinberg School of Medicine and a Clinical Attending at Ann & Robert H. Lurie Children's Hospital of Chicago. She has more than 15 years of experience as a board-certified pediatrician and health researcher and currently serves as the director of the Science and Outcomes of Allergy & Asthma Research Program (SOAAR), where she is actively involved in clinical, epidemiological, and community-based research.
She is nationally recognized for her groundbreaking research in the areas of food allergy and asthma epidemiology; specifically for her research on childhood food allergy prevalence. Dr. Gupta has also significantly contributed to academic research surrounding the economic impact of food allergy, pediatric management of food allergy and asthma, implementing community-based interventions in schools to improve outcomes, and improving the quality of life of children and their caregivers.
Dr. Gupta strives to improve the lives of children and their families through her research and hopes to continue finding answers and shaping policies surrounding pediatric food allergy and asthma.
Interim Chief of Research Strategy & Innovation
Nurry has over 18 years of experience advising leading for-profit and not-for-profit healthcare organizations shape and execute their organization’s growth strategies. His previous experience includes over eight years as a Managing Director and Partner of L.E.K. Consulting’s Life Sciences practice where he helped contribute to the firm’s global, U.S. and West Coast operations. Nurry’s expertise is in corporate strategy and development, portfolio optimization and planning, business development and transactions, commercialization, market access and operational scale-up with a focus on biopharma, medical device and integrated health technology companies. While at L.E.K., Nurry worked closely with C-suite executives, board members and investors at leading global healthcare and biopharmaceutical companies, emerging innovative start-ups and industry-shaping venture funds. His not-for-profit experience includes working closely with large medical research foundations including leading organizations in global health, Type 1 Diabetes and neurosciences. He is currently a co-founder and CEO of two start-up life science companies, and serves as a board observer and advisor to various private and not-for-profit organizations. Nurry has a B.A. in Finance from the University of Washington. Nurry is a food allergy dad and passionate advocate for food allergy patients and families.
Vice President and Senior Advisor
Jen supports content, advocacy and strategic partnerships and serves as a subject matter expert across all programmatic areas. The mother of two children, one of whom has food allergies, Jen has worked professionally in the food allergy world since opening the Chicago office of the Food Allergy Initiative in 2010. She began her career at the Illinois Attorney General’s office, and has worked in senior executive positions in several philanthropic foundations. She received her MA from The University of Chicago, BA from Bryn Mawr College, and has lived in the UK, France and Israel.
Mary Jane Marchisotto
Senior Vice President of Research and International Operations
Before joining FARE, Mary Jane spent more than 30 years in the financial services industry, including at JP Morgan Chase, Citibank and Morgan Stanley, concentrating on financial management issues and on the development of internal best practices. Mary Jane was previously the Executive Director of FAI. She serves as co-chair of the Patient Organization Committee of the European Academy of Allergy and Clinical Immunology, chair of the International Food and Anaphylaxis Alliance, is a member of the Adverse Reactions Committee of The American Academy of Allergy Asthma and Immunology and is serving on the Sharing Clinical Trial Data Action Collaborative of the National Academy of Medicine. She is a graduate of Wells College and holds an MBA in Finance from Columbia Business School.
Kari Nadeau, MD, PhD
Medical Advisor, Innovation
Dr. Kari Nadeau is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University and is an endowed professor under the Naddisy Family Foundation. Her work has been recognized with numerous grants and awards, and her research is part of a prestigious Clinical and Translational Science Award from the National Institutes of Health (NIH).
Dr. Nadeau has received honors and awards from the American Academy of Allergy, Asthma & Immunology; the American Lung Association; the Clinical Immunological Society; Food Allergy Research & Education (FARE); and the NIH. She has also been recognized with the U.S. Environmental Protection Agency’s STAR Grant Award.
Dr. Nadeau received her MD and PhD from Harvard Medical School. She completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in asthma and immunology at Stanford and University of California, San Francisco. She has been a faculty member at Lucile Packard Children’s Hospital Stanford since 2006. She has authored or co-authored more than 160 peer-reviewed manuscripts.
Wayne Shreffler, MD, PhD
Medical Advisor, Research
Dr. Wayne Shreffler is the Director of the Food Allergy Center, Massachusetts General Hospital; Division Chief, Pediatric Allergy and Immunology at MassGeneral Hospital of Children; Associate Professor of Pediatrics, Harvard Medical School and Associate Member of the Broad Institute - Food Allergy Science Initiative.
Dr. Shreffler received his MD and PhD degrees from New York University and his Pediatrics training at the Albert Einstein College of Medicine. He completed his fellowship in Allergy & Immunology at the Mount Sinai School of Medicine. He joined Massachusetts General Hospital and Harvard Medical School in late 2009 to establish a new translational research and clinical care center focused on food allergy and he became Division Chief of Pediatric Allergy and Immunology in 2011.
The food allergy program at Massachusetts General Hospital is an integrated research and multi-disciplinary clinical effort to advance the care for patients and better understand the pathogenic mechanisms of IgE-mediated hypersensiivity in the context of food allergy. The Shreffler laboratory focuses on the characterization of cellular and humoral immune response to dietary antigens and the mechanisms of allergen-induced Th2 sensitization and oral tolerance. Dr. Shreffler has authored more than 70 papers, maintained continuous NIH and other research funding since 2007, served on the editorial board of the Journal of Allergy and Clinical Immunology and as reviewer for numerous journals and grant study sections / committees. He was elected a Fellow of the AAAAI in 2009.
Brian Vickery, MD
Medical Advisor, Patient Experience
Brian Vickery is an Associate Professor of Pediatrics at Emory University and the founding Director of the Food Allergy Center at Children’s Healthcare of Atlanta. His clinical and research efforts focus on understanding the pathophysiology of food allergies and anaphylaxis, and developing new therapies to treat them.
Dr. Vickery completed his undergraduate work at the University of Georgia and obtained his medical degree from the Medical College of Georgia. He completed his pediatric residency and chief residency at New York-Presbyterian Hospital/Weill Cornell Medical Center, and his fellowship training in allergy & clinical immunology at Yale University School of Medicine. He subsequently held faculty positions at Duke University School of Medicine and then the University of North Carolina School of Medicine, where he was an NIH-funded researcher and the Director of the UNC Food Allergy Initiative.
Dr. Vickery has published over 50 papers in leading journals and was most recently the lead author of a study published in the New England Journal of Medicine reporting results of a Phase 3 randomized clinical trial of peanut OIT, the largest of its kind. He also serves as a peer reviewer for high-impact allergy journals and grant agencies, as well as a journal section editor. He has presented his work at national and international meetings and has contributed to the development of national food allergy treatment guidelines.
What to Read Next
FARE formed in 2012 when two reputable organizations merged: the Food Allergy & Anaphylaxis Network (FAAN) and the Food Allergy Initiative (FAI).
The FARE Clinical Network brings top institutions together to ensure that patients with food allergies have access to state-of-the-art diagnosis, care, research and clinical trials.
The FARE website was my go-to place when my daughter was first diagnosed over a decade ago. Now that her needs have changed, as she has grown, I can see that FARE is in step with those of all ages and stages."